714 related articles for article (PubMed ID: 14693694)
1. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
2. Effect of gender on lipid-induced insulin resistance in obese subjects.
Vistisen B; Hellgren LI; Vadset T; Scheede-Bergdahl C; Helge JW; Dela F; Stallknecht B
Eur J Endocrinol; 2008 Jan; 158(1):61-8. PubMed ID: 18166818
[TBL] [Abstract][Full Text] [Related]
3. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.
Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801
[TBL] [Abstract][Full Text] [Related]
4. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.
Serlie MJ; Meijer AJ; Groener JE; Duran M; Endert E; Fliers E; Aerts JM; Sauerwein HP
J Clin Endocrinol Metab; 2007 Apr; 92(4):1524-9. PubMed ID: 17264178
[TBL] [Abstract][Full Text] [Related]
5. Muscle adaptation to short-term fasting in healthy lean humans.
Soeters MR; Sauerwein HP; Dubbelhuis PF; Groener JE; Ackermans MT; Fliers E; Aerts JM; Serlie MJ
J Clin Endocrinol Metab; 2008 Jul; 93(7):2900-3. PubMed ID: 18397976
[TBL] [Abstract][Full Text] [Related]
6. Muscle-Saturated Bioactive Lipids Are Increased with Aging and Influenced by High-Intensity Interval Training.
Søgaard D; Baranowski M; Larsen S; Taulo Lund M; Munk Scheuer C; Vestergaard Abildskov C; Greve Dideriksen S; Dela F; Wulff Helge J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871020
[TBL] [Abstract][Full Text] [Related]
7. Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.
Skovbro M; Baranowski M; Skov-Jensen C; Flint A; Dela F; Gorski J; Helge JW
Diabetologia; 2008 Jul; 51(7):1253-60. PubMed ID: 18458871
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content.
Coen PM; Dubé JJ; Amati F; Stefanovic-Racic M; Ferrell RE; Toledo FG; Goodpaster BH
Diabetes; 2010 Jan; 59(1):80-8. PubMed ID: 19833891
[TBL] [Abstract][Full Text] [Related]
9. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
11. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
12. Evidence for increased and insulin-resistant lipolysis in skeletal muscle of high-fat-fed rats.
Guo Z; Zhou L
Metabolism; 2004 Jun; 53(6):794-8. PubMed ID: 15164331
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
Kruszynska YT; Worrall DS; Ofrecio J; Frias JP; Macaraeg G; Olefsky JM
J Clin Endocrinol Metab; 2002 Jan; 87(1):226-34. PubMed ID: 11788651
[TBL] [Abstract][Full Text] [Related]
14. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle.
Straczkowski M; Kowalska I; Nikolajuk A; Dzienis-Straczkowska S; Kinalska I; Baranowski M; Zendzian-Piotrowska M; Brzezinska Z; Gorski J
Diabetes; 2004 May; 53(5):1215-21. PubMed ID: 15111489
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
17. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
18. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
19. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.
Levin K; Daa Schroeder H; Alford FP; Beck-Nielsen H
Diabetologia; 2001 Jul; 44(7):824-33. PubMed ID: 11508266
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys.
Pender C; Ortmeyer HK; Hansen BC; Goldfine ID; Youngren JF
Metabolism; 2002 Apr; 51(4):465-70. PubMed ID: 11912555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
